GrowthCap Announces The Top 25 Healthcare Investors of 2022
The 2022 awardees represent a diverse set of individuals with backgrounds in medicine, science, and technology in addition to finance and investing.
NEW YORK, April 27, 2022 /PRNewswire-PRWeb/ -- GrowthCap is pleased to announce The Top 25 Healthcare Investors of 2022. Over 800 investors were considered at the start of this year's nomination process. To determine the awardees, we focused on feedback received from portfolio company CEOs, firm colleagues and peers in the industry as well as our own proprietary research. The 2022 awardees represent a diverse set of individuals with backgrounds in medicine, science, and technology in addition to finance and investing. Across growth equity and growth buyouts in addition to emerging growth and venture, what these investors all have in common is demonstrated exceptional performance in the areas of investment selection, value creation, and ESG engagement.
This year's awardees were nominated by their firms, portfolio companies, healthcare industry colleagues, and/or peers at other investment firms. More specifically, awardee selections and rankings were based on deal experience and track record, strategic and operational capabilities provided to portfolio companies, unique and differentiated attributes, as well as contributions to ESG, DEI, charitable work, and overall industry advancement. Healthcare plays a critical role in the quality of our lives, underpins all other business and economic activity, and ultimately determines the state of our world.
Please join us in recognizing and celebrating the achievements of The Top 25 Healthcare Investors of 2022.
Chris Gordon, Devin O'Reilly (Bain Capital), Jeff Rhodes (TPG Capital), Garheng Kong (HealthQuest Capital), Chelsea Stoner (Battery Ventures), Robb Vorhoff (General Atlantic), Matt Hobart (TPG Growth), Joshua Nelson (Thomas H. Lee Partners), Jeff Crisan (Silversmith Capital Partners), Ryan Drant (Questa Capital), Andrew Lindner (Frontier Growth), Bradley Sloan (Questa Capital), Lonne Jaffe (Insight Partners), David Schuppan (The Vistria Group), Greg Moerschel (BPOC), Lenard Marcus (Edison Partners), Matt Emery (JMI Equity), Jonathan Rosenbaum (Insight Partners), Laura Veroneau (Optum Ventures), Ezra Mehlman (Health Enterprise Partners), Sureel Sheth (JMI Equity), Leon Chen (Kayne Anderson), Matt Carroll (WestView Capital Partners), William Dai (ShangBay Capital), Lucio Iannone (Leaps by Bayer), Rami El Assal (Boutique Venture Partners)
The full article can be read at https://growthcapadvisory.com/.
About GrowthCap
GrowthCap's primary focus is to aid CEOs in better understanding the universe of capital alternatives offered by institutional investors such as private equity firms, growth equity firms, venture capital and family offices. GrowthCap also aims to provide CEOs with insights into how other entrepreneurs and executives have succeeded in scaling their businesses. While emphasis has been on select sectors including business software, business services, healthcare and consumer products and services, GrowthCap is often involved in other segments of the broader economy.
Media Contact
GC Editor, GrowthCap, 1 646-470-3188, [email protected]
SOURCE GrowthCap
Share this article